Comparison of Visfatin and Leptin Levels in Type 2 Diabetic Patients with and without Atherosclerosis

Medical evidence shows that Visfatin and Leptin are related to multiple metabolic Problems, including obesity, type 2 diabetes, and cardiovascular disease. The present study aimed to assess Visfatin and Leptin levels in type 2 diabetic patients with and without atherosclerosis.
Instruments &

This descriptive study was conducted on 30 diabetic patients, 30 patients with diabetes mellitus and atherosclerosis, and 30 seemingly healthy persons (as a control group) in Babylon Province, Iraq, and their serum Visfatin and Leptin levels were assessed by ELISA procedure. The statistical analysis was done with SPSS 21 software.

In diabetic patients and patients with diabetes and atherosclerosis, the level of Visfatin was significantly higher than in the control group (p=0.0001). There was a significant increase in Leptin level in diabetic patients compared to the control group (p=0.0001), while Leptin level showed a significant decrease in patients with diabetes and atherosclerosis than in the control group (p=0.0001). Also, the mean body mass index in diabetic patients and patients with diabetes and atherosclerosis was significantly higher than in the control group (p=0.0001).

Visfatin serum levels are significantly higher in atherosclerosis patients compared to healthy people, while low Leptin and high Visfatin expression are seen in patients with diabetes.